Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has disclosed that it received a “Not guilty” verdict in the second-instance court ruling (Seoul High Court) regarding alleged accounting rule violations. The company plans to issue a correction disclosure upon receipt of the written judgment.
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: Results of Measures Such as Prosecution Notice for Breach of Accounting Standards
- Result of Measure: Not guilty
- Main Alleged Violations: No violations
- Competent Court / Authority: Seoul High Court
- Judgment / Decision Date: February 3, 2025 (Date of second-instance judgment rendering)
- Date of Confirmation: February 3, 2025
- Future Countermeasures: Taking necessary measures including enhancing accounting transparency and strengthening internal monitoring mechanisms
- Other Important Details:
- This disclosure is based on the second-instance ruling and is subject to change depending on potential Supreme Court appeals and rulings.
- The company has not yet received the written judgment as of this filing and plans to issue a correction disclosure upon receipt.
- Subsequent progress and confirmed facts will be re-disclosed as they arise.
- Related Disclosures:
- July 12, 2018: Measures Such as Prosecution Notice for Breach of Accounting Standards
- November 14, 2018: Measures Such as Prosecution Notice for Breach of Accounting Standards
- September 04, 2020: Measures Such as Prosecution Notice for Breach of Accounting Standards
- February 05, 2024: Results of Measures Such as Prosecution Notice for Breach of Accounting Standards
- February 08, 2024: Results of Measures Such as Prosecution Notice for Breach of Accounting Standards
- February 08, 2024: Measures Such as Prosecution Notice for Breach of Accounting Standards
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Second-Instance Ruling and Correction Disclosure Upon Receipt of Written Judgment
This disclosure provides notice of the second-instance court ruling (Not guilty) rendered by the Seoul High Court.
Tracking the upcoming correction disclosure following receipt of the written judgment and checking potential prosecution appeals is essential.
Relevant details can be verified in subsequent official disclosures regarding legal developments.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
